This book examines how government, industry and society interact to
reach a level of regulation that is deemed satisfactory for the
newly-emerged transformative technology that is agricultural
biotechnology. It considers issues of risk and trust surrounding
genetically-modified plants for the production of food and
pharmaceuticals. It describes how regulations have been produced to
manage, or in some cases ignore, the risks from GM products. The scope
is international and the book makes a significant contribution to the
literature in this growing field of interest.